Description

Buy Tirzepatide 10MG Peptide AUS

 Tirzepatide 10mg Vial – Dual GLP-1/GIP Research Peptide

 Product Overview

Tirzepatide is a next-generation dual agonist peptide that targets both GLP-1 and GIP receptors, offering synergistic benefits for metabolic health, appetite regulation, and body composition.
Originally designed for research into obesity and insulin resistance, Tirzepatide has shown exceptional potential in supporting fat metabolism, glucose control, and energy balance.

 Key Features

 Dual GLP-1 + GIP Action – Enhances metabolic signaling and fat utilization.
 Supports Fat Reduction – Shown to reduce adipose accumulation in research models.
 Appetite Control – Promotes natural calorie regulation via gut–brain signaling.
 Improved Insulin Sensitivity – Helps optimize glucose uptake and reduce spikes.
 Preserves Lean Mass – Encourages muscle protection during caloric deficit.
 Long-Acting Formula – Weekly administration for steady metabolic balance.

 Specifications

• Peptide: Tirzepatide
• Purity: ≥ 99% (HPLC Tested)
• Form: Lyophilized powder
• Content: 10mg per vial
• Storage: Store at 2–8°C; protect from light and moisture

 Suggested Research Stacks

Enhance metabolic outcomes and mitochondrial function by pairing Tirzepatide with synergistic peptides:

 Research Use Only

Not for human consumption. For laboratory, scientific, or educational research purposes only.

 Suggested Pairing Example

Tirzepatide + MOTS-c + 5-Amino-1MQ Stack
→ Combines appetite regulation, mitochondrial activation, and NAD+ support for comprehensive metabolic optimization (simulation purposes only).